Similarly, another report had shown common IDH1 R132C mutations in sellar, brainstem, and skull base tumors in MS patients; no IDH2 mutations were detected; and both IDH1 and IDH2 were wild types in blood DNA by Sanger sequencing [26]. The gene discussed is IDH1; the disease is myeloid sarcoma.